GRPEL2 and cancer: Our putative NEF ortholog, GRPEL2, modulates mitochondrial HSP70′s function in human GBM cell lines, suggesting that GRPEL2 has evolved as a possible anti-tumor hub emerging into modern cancer medicine [6,13].